1609-06-9: Cimetidine EP Impurity G
It is one of impurity present in Cimetidine, Cimetidine is a histamine H2 receptor antagonist, It reduces basal and nocturnal gastric acid secretion and reduction in gastric volume, acidity, and amount of gastric acid released in response to stimuli including food, caffeine, insulin, and pentagastrin. which is used to treat gastrointestinal disorders such as gastric ulcers, gastroesophageal reflux disease, and pathological hypersecretory conditions. Cimetidine inhibits isoenzymes of the hepatic CYP450 enzyme system and also increases gastric bacterial flora such as nitrate-reducing organisms.
Additional information on CAS 1609-06-9
VE006613
1609-06-9
C4H8N4
112.13
Cimetidine
2-Cyano-1, 3-dimethylguanidine
N/A
Das, B. B., Anton, K., Soares, N., Riojas, S., Mcdermott, J., Knox, L., … Puente, B. N. (2018). Cimetidine: A Safe Treatment Option for Cutaneous Warts in Pediatric Heart Transplant Recipients. Medical Sciences, 6(2), 30. https://doi.org/10.3390/medsci6020030
In-stock
Other products related to cimetidine
Name of Impurity | Catalogue No. | |
---|---|---|
Cimetidine EP Impurity A | VE006609 | View CAS 52378-40-2 |
Cimetidine EP Impurity B | VL1900002 | View CAS 138035-55-9 |
Cimetidine EP Impurity C (Free Base) | VE006610 | View CAS 77076-18-7 |
Cimetidine EP Impurity D(Free Base) | VE006611 | View CAS 70172-53-1 |
Cimetidine EP Impurity E | VE006612 | View CAS 54237-72-8 |
Cimetidine EP Impurity F | VL1900001 | View CAS 55272-86-1 |
Cimetidine EP Impurity H | VE006614 | View CAS 74886-59-2 |
4-Hydroxymethyl-5-methylimidazole | VE008009 | View CAS 29636-87-1 |